EP12.01-35 Skin Toxicity Associated with Targeted and Immune Therapies in Stage IV Lung Cancer Patients: A 14-year Cohort von Yang, P., Peng, Y., Kumar, A.V., Gu, Z., Kosuru, N., Wampfler, J.A., Reck dos Santos, P.A., Yu, N.Y., D'Cunha, J., Costello, C.M., Ernani, V.

Volltext

EP.07C.16 Real-World Outcomes of Patients with Resectable Early-Stage Non-Small Cell Lung Cancer Treated with Neoadjuvant Chemoimmunotherapy von Hazim, A., Xiao, A., Singh, A., Chung, K., Reck dos Santos, P.A., D'Cunha, J., Shanshal, M., Dimou, A., Parikh, K., Lou, Y., Manochakian, R., Leventakos, K., Molina, J., Mansfield, A., Ernani, V.

Volltext